Trial Profile
A Randomized, Open-label, Active Control Trial to Evaluate the Effect of LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Atenolol; Propranolol
- Indications Aortic disorders; Marfan syndrome
- Focus Therapeutic Use
- 12 Jan 2013 Primary endpoint 'ECG-changes' has been met.
- 12 Jan 2013 Status changed from recruiting to completed.
- 18 Feb 2011 New trial record